These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 26299203

  • 1. Analysis of the differential expression of circulating microRNAs during the progression of hepatic fibrosis in patients with chronic hepatitis B virus infection.
    Zhang Q, Xu M, Qu Y, Li Z, Zhang Q, Cai X, Lu L.
    Mol Med Rep; 2015 Oct; 12(4):5647-54. PubMed ID: 26299203
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA profile analysis in the liver fibrotic tissues of chronic hepatitis B patients.
    Chen R, Wu JC, Liu T, Qu Y, Lu LG, Xu MY.
    J Dig Dis; 2017 Feb; 18(2):115-124. PubMed ID: 28127890
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. miR-98-5p as a novel biomarker suppress liver fibrosis by targeting TGFβ receptor 1.
    Ma Y, Yuan X, Han M, Xu Y, Han K, Liang P, Liu S, Chen J, Xing H.
    Hepatol Int; 2022 Jun; 16(3):614-626. PubMed ID: 35188624
    [Abstract] [Full Text] [Related]

  • 6. Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression.
    Yang G, Yang L, Wang W, Wang J, Wang J, Xu Z.
    Gene; 2015 May 10; 562(1):138-44. PubMed ID: 25725128
    [Abstract] [Full Text] [Related]

  • 7. Profiles of differential expression of circulating microRNAs in hepatitis B virus-positive small hepatocellular carcinoma.
    Wang Y, Gao Y, Shi W, Zhai D, Rao Q, Jia X, Liu J, Jiao X, Du Z.
    Cancer Biomark; 2015 May 10; 15(2):171-80. PubMed ID: 25519019
    [Abstract] [Full Text] [Related]

  • 8. Changes in microRNA expression during disease progression in patients with chronic viral hepatitis.
    Sinigaglia A, Lavezzo E, Trevisan M, Sanavia T, Di Camillo B, Peta E, Scarpa M, Castagliuolo I, Guido M, Sarcognato S, Cappellesso R, Fassina A, Cardin R, Farinati F, Palù G, Barzon L.
    Liver Int; 2015 Apr 10; 35(4):1324-33. PubMed ID: 25417901
    [Abstract] [Full Text] [Related]

  • 9. A serum microRNA signature is associated with the immune control of chronic hepatitis B virus infection.
    Brunetto MR, Cavallone D, Oliveri F, Moriconi F, Colombatto P, Coco B, Ciccorossi P, Rastelli C, Romagnoli V, Cherubini B, Teilum MW, Blondal T, Bonino F.
    PLoS One; 2014 Apr 10; 9(10):e110782. PubMed ID: 25350115
    [Abstract] [Full Text] [Related]

  • 10. Characterization of gene expression profiles in HBV-related liver fibrosis patients and identification of ITGBL1 as a key regulator of fibrogenesis.
    Wang M, Gong Q, Zhang J, Chen L, Zhang Z, Lu L, Yu D, Han Y, Zhang D, Chen P, Zhang X, Yuan Z, Huang J, Zhang X.
    Sci Rep; 2017 Mar 06; 7():43446. PubMed ID: 28262670
    [Abstract] [Full Text] [Related]

  • 11. Circulating microRNAs in hepatitis B virus-infected patients.
    Ji F, Yang B, Peng X, Ding H, You H, Tien P.
    J Viral Hepat; 2011 Jul 06; 18(7):e242-51. PubMed ID: 21692939
    [Abstract] [Full Text] [Related]

  • 12. The Diagnosis Value of a Novel Model with 5 Circulating miRNAs for Liver Fibrosis in Patients with Chronic Hepatitis B.
    Zhang Q, Zhang Q, Li B, Qu Y, Li Z, Lu L, Li R, Cai X.
    Mediators Inflamm; 2021 Jul 06; 2021():6636947. PubMed ID: 33727891
    [Abstract] [Full Text] [Related]

  • 13. Characterization and identification of differentially expressed microRNAs during the process of the peribiliary fibrosis induced by Clonorchis sinensis.
    Yan C, Shen LP, Ma R, Li B, Li XY, Hua H, Zhang B, Yu Q, Wang YG, Tang RX, Zheng KY.
    Infect Genet Evol; 2016 Sep 06; 43():321-8. PubMed ID: 27267304
    [Abstract] [Full Text] [Related]

  • 14. Expression Profiling of Cellular MicroRNA in Asymptomatic HBsAg Carriers and Chronic Hepatitis B Patients.
    Hou X, Liang Y, Chen J, Wei Y, Zeng P, Wang L, Lu C, Diao H.
    Biomed Res Int; 2017 Sep 06; 2017():6484835. PubMed ID: 28913356
    [Abstract] [Full Text] [Related]

  • 15. Serum high-sensitivity C-reactive protein are associated with HBV replication, liver damage and fibrosis in patients with chronic hepatitis B.
    Ma LN, Liu XY, Luo X, Hu YC, Liu SW, Tang YY, Pan JL, Ding XC.
    Hepatogastroenterology; 2015 Sep 06; 62(138):368-72. PubMed ID: 25916065
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA Expression Profiling in CCl₄-Induced Liver Fibrosis of Mus musculus.
    Hyun J, Park J, Wang S, Kim J, Lee HH, Seo YS, Jung Y.
    Int J Mol Sci; 2016 Jun 17; 17(6):. PubMed ID: 27322257
    [Abstract] [Full Text] [Related]

  • 17. Circulating microRNAs as non-invasive biomarkers for hepatitis B virus liver fibrosis.
    Iacob DG, Rosca A, Ruta SM.
    World J Gastroenterol; 2020 Mar 21; 26(11):1113-1127. PubMed ID: 32231417
    [Abstract] [Full Text] [Related]

  • 18. [Level of serum and liver tissue TGF-beta1 in patients with liver fibrosis due to chronic hepatitis B].
    Guo JC, Bao JF, Chen QW, Li XO, Shi JP, Lou GQ, Shi WZ, Xun YH.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct 21; 22(5):354-7. PubMed ID: 19469173
    [Abstract] [Full Text] [Related]

  • 19. Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.
    Zhang S, Ouyang X, Jiang X, Gu D, Lin Y, Kong SK, Xie W.
    Int J Med Sci; 2015 Oct 21; 12(7):590-8. PubMed ID: 26283876
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.